Vespa crabro chromosome 12, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342411.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124428438, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC124428438, transcript variant X7
uncharacterized LOC124428438, transcript variant X2
uncharacterized LOC124428438, transcript variant X3
uncharacterized LOC124428438, transcript variant X6
uncharacterized LOC124428438, transcript variant X5
uncharacterized LOC124428438, transcript variant X1
probable glutamate receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable glutamate receptor, transcript variant X1
glutamate receptor ionotropic, delta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
cytochrome P450 4V2-like, transcript variant X1
cytochrome P450 4V2-like, transcript variant X3
cytochrome P450 4V2-like, transcript variant X4
cytochrome P450 4V2-like, transcript variant X2
uncharacterized protein LOC124428282 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
glutamate receptor ionotropic, kainate 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome P450 4C1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cytochrome P450 4C1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor 3-like, transcript variant X6
glutamate receptor 3-like, transcript variant X5
glutamate receptor 3-like, transcript variant X8
glutamate receptor 3-like, transcript variant X3
glutamate receptor 3-like, transcript variant X1
glutamate receptor 3-like, transcript variant X4
glutamate receptor 3-like, transcript variant X7
glutamate receptor 3-like, transcript variant X2
glutamate receptor ionotropic, kainate 5-like isoform X5
glutamate receptor 3-like, transcript variant X9
glutamate receptor 3-like, transcript variant X10
glutamate receptor ionotropic, kainate 2-like isoform X8
glutamate receptor ionotropic, kainate 2-like isoform X7
uncharacterized LOC124428288, transcript variant X1
uncharacterized LOC124428288, transcript variant X2
uncharacterized LOC124428288, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
uncharacterized LOC124428315, transcript variant X1
uncharacterized LOC124428315, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 49% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 4C1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124428318, transcript variant X4
uncharacterized LOC124428318, transcript variant X3
uncharacterized LOC124428318, transcript variant X2
uncharacterized LOC124428318, transcript variant X5
uncharacterized LOC124428318, transcript variant X1
uncharacterized protein LOC124428318 isoform X3
uncharacterized protein LOC124428318 isoform X2
uncharacterized protein LOC124428318 isoform X4
uncharacterized protein LOC124428318 isoform X1
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase N, transcript variant X3
serine/threonine-protein kinase N, transcript variant X2
serine/threonine-protein kinase N, transcript variant X1
serine/threonine-protein kinase N, transcript variant X4
serine/threonine-protein kinase N isoform X3
serine/threonine-protein kinase N isoform X2
serine/threonine-protein kinase N isoform X1
serine/threonine-protein kinase N isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
conserved oligomeric Golgi complex subunit 6, transcript variant X1
conserved oligomeric Golgi complex subunit 6, transcript variant X2
conserved oligomeric Golgi complex subunit 6 isoform X1
conserved oligomeric Golgi complex subunit 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
b(0,+)-type amino acid transporter 1-like, transcript variant X3
b(0,+)-type amino acid transporter 1-like, transcript variant X2
b(0,+)-type amino acid transporter 1-like, transcript variant X1
b(0,+)-type amino acid transporter 1-like isoform X1
b(0,+)-type amino acid transporter 1-like isoform X2
ZZ-type zinc finger-containing protein 3
queuine tRNA-ribosyltransferase accessory subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124428484, transcript variant X6
uncharacterized LOC124428484, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124428484, transcript variant X3
uncharacterized protein LOC124428484 isoform X6
uncharacterized protein LOC124428484 isoform X1
uncharacterized protein LOC124428484 isoform X3
uncharacterized LOC124428484, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC124428484 isoform X4
uncharacterized LOC124428484, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC124428484 isoform X5
uncharacterized LOC124428484, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC124428484 isoform X2
uncharacterized LOC124428484, transcript variant X8
uncharacterized protein LOC124428484 isoform X8
uncharacterized LOC124428484, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC124428484 isoform X7
homeobox protein araucan-like, transcript variant X1
homeobox protein araucan-like isoform X1
homeobox protein araucan-like, transcript variant X2
homeobox protein araucan-like isoform X2
uncharacterized LOC124428350, transcript variant X2
uncharacterized LOC124428350, transcript variant X1
iroquois-class homeodomain protein IRX-6-like
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X7
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X10
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X6
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X9
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X3
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X5
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X1
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X8
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X2
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X4
probable serine/threonine-protein kinase DDB_G0282963 isoform X2
probable serine/threonine-protein kinase DDB_G0282963 isoform X3
probable serine/threonine-protein kinase DDB_G0282963 isoform X1
probable serine/threonine-protein kinase DDB_G0282963 isoform X4
ATP-binding cassette sub-family F member 2
transmembrane protein 98-like, transcript variant X2
transmembrane protein 98-like isoform X2
transmembrane protein 98-like, transcript variant X1
transmembrane protein 98-like isoform X1
ubiquitin-conjugating enzyme E2 J2, transcript variant X2
ubiquitin-conjugating enzyme E2 J2, transcript variant X1
ubiquitin-conjugating enzyme E2 J2 isoform X1
ubiquitin-conjugating enzyme E2 J2 isoform X2
protein twist-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein twist-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein twist-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myb-like protein AA, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myb-like protein AA, transcript variant X1
myb-like protein AA, transcript variant X4
myb-like protein AA, transcript variant X2
myb-like protein AA, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124428444, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124428444, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Bardet-Biedl syndrome 7 protein homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Bardet-Biedl syndrome 7 protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Bardet-Biedl syndrome 7 protein homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Bardet-Biedl syndrome 7 protein homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Bardet-Biedl syndrome 7 protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Bardet-Biedl syndrome 7 protein homolog isoform X1
Bardet-Biedl syndrome 7 protein homolog isoform X2
Bardet-Biedl syndrome 7 protein homolog isoform X3
zinc finger protein 45-like, transcript variant X2
zinc finger protein 45-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 45-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
trinucleotide repeat-containing gene 6C protein, transcript variant X1
trinucleotide repeat-containing gene 6C protein, transcript variant X3
trinucleotide repeat-containing gene 6C protein, transcript variant X6
trinucleotide repeat-containing gene 6C protein, transcript variant X4
trinucleotide repeat-containing gene 6C protein, transcript variant X5
trinucleotide repeat-containing gene 6C protein, transcript variant X2
trinucleotide repeat-containing gene 6C protein isoform X1
trinucleotide repeat-containing gene 6C protein isoform X2
trinucleotide repeat-containing gene 6C protein isoform X5
trinucleotide repeat-containing gene 6C protein isoform X3
trinucleotide repeat-containing gene 6C protein isoform X4
protein KRTCAP2 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein KRTCAP2 homolog, transcript variant X1
diacylglycerol O-acyltransferase 1, transcript variant X7
diacylglycerol O-acyltransferase 1, transcript variant X11
diacylglycerol O-acyltransferase 1, transcript variant X4
diacylglycerol O-acyltransferase 1, transcript variant X5
diacylglycerol O-acyltransferase 1, transcript variant X8
diacylglycerol O-acyltransferase 1, transcript variant X9
diacylglycerol O-acyltransferase 1, transcript variant X6
diacylglycerol O-acyltransferase 1, transcript variant X10
diacylglycerol O-acyltransferase 1, transcript variant X2
diacylglycerol O-acyltransferase 1, transcript variant X3
diacylglycerol O-acyltransferase 1 isoform X2
diacylglycerol O-acyltransferase 1 isoform X3
diacylglycerol O-acyltransferase 1, transcript variant X1
diacylglycerol O-acyltransferase 1 isoform X1
uncharacterized LOC124428468, transcript variant X3
uncharacterized LOC124428468, transcript variant X2
uncharacterized LOC124428468, transcript variant X1
uncharacterized LOC124428468, transcript variant X4
probable GPI-anchored adhesin-like protein PGA55, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable GPI-anchored adhesin-like protein PGA55, transcript variant X1
probable GPI-anchored adhesin-like protein PGA55 isoform X2
ranBP-type and C3HC4-type zinc finger-containing protein 1-like
39S ribosomal protein L10, mitochondrial
homeobox protein ceh-30-like, transcript variant X1
homeobox protein ceh-30-like, transcript variant X2
homeobox protein ceh-30-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
homeotic protein distal-less, transcript variant X5
homeotic protein distal-less, transcript variant X6
homeotic protein distal-less, transcript variant X2
homeotic protein distal-less, transcript variant X7
homeotic protein distal-less, transcript variant X3
homeotic protein distal-less, transcript variant X4
homeotic protein distal-less, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124428499, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124428499, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate decarboxylase, transcript variant X1
glutamate decarboxylase, transcript variant X2
uncharacterized LOC124428499, transcript variant X3
fumarylacetoacetase, transcript variant X2
fumarylacetoacetase, transcript variant X1
fas apoptotic inhibitory molecule 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fas apoptotic inhibitory molecule 1, transcript variant X1
coiled-coil domain-containing protein 113-like, transcript variant X2
coiled-coil domain-containing protein 113-like, transcript variant X1
coiled-coil domain-containing protein 113-like isoform X1
coiled-coil domain-containing protein 113-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM domain-containing protein jub-like, transcript variant X2
LIM domain-containing protein jub-like, transcript variant X3
LIM domain-containing protein jub-like, transcript variant X1
LIM domain-containing protein jub-like isoform X2
LIM domain-containing protein jub-like isoform X1
uncharacterized LOC124428502, transcript variant X2
putative uncharacterized protein DDB_G0277255, transcript variant X1
putative uncharacterized protein DDB_G0277255, transcript variant X2
putative uncharacterized protein DDB_G0277255
uncharacterized LOC124428502, transcript variant X1
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X2
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X4
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X3
voltage-dependent L-type calcium channel subunit beta-2, transcript variant X1
voltage-dependent L-type calcium channel subunit beta-2 isoform X2
voltage-dependent L-type calcium channel subunit beta-2 isoform X4
voltage-dependent L-type calcium channel subunit beta-2 isoform X3
voltage-dependent L-type calcium channel subunit beta-2 isoform X1
uncharacterized LOC124428507, transcript variant X1
uncharacterized LOC124428507, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 13-like, transcript variant X1
zinc finger CCCH domain-containing protein 13-like isoform X1
zinc finger CCCH domain-containing protein 13-like, transcript variant X2
zinc finger CCCH domain-containing protein 13-like isoform X2
uncharacterized LOC124428506, transcript variant X5
uncharacterized LOC124428506, transcript variant X6
uncharacterized LOC124428506, transcript variant X3
uncharacterized LOC124428506, transcript variant X1
uncharacterized LOC124428506, transcript variant X2
uncharacterized LOC124428506, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5 isoform X2
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X1
UDP-N-acetylhexosamine pyrophosphorylase, transcript variant X2
UDP-N-acetylhexosamine pyrophosphorylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ADP-ribosylation factor 6, transcript variant X4
ADP-ribosylation factor 6, transcript variant X2
ADP-ribosylation factor 6, transcript variant X1
ADP-ribosylation factor 6, transcript variant X6
ADP-ribosylation factor 6, transcript variant X3
ADP-ribosylation factor 6, transcript variant X5
NF-kappa-B-repressing factor, transcript variant X3
NF-kappa-B-repressing factor, transcript variant X1
NF-kappa-B-repressing factor, transcript variant X2
NF-kappa-B-repressing factor, transcript variant X4
microtubule-actin cross-linking factor 1, transcript variant X28
microtubule-actin cross-linking factor 1, transcript variant X27
microtubule-actin cross-linking factor 1, transcript variant X23
microtubule-actin cross-linking factor 1, transcript variant X19
microtubule-actin cross-linking factor 1, transcript variant X16
microtubule-actin cross-linking factor 1, transcript variant X40
microtubule-actin cross-linking factor 1, transcript variant X38
microtubule-actin cross-linking factor 1, transcript variant X39
microtubule-actin cross-linking factor 1, transcript variant X17
microtubule-actin cross-linking factor 1, transcript variant X25
microtubule-actin cross-linking factor 1, transcript variant X18
microtubule-actin cross-linking factor 1, transcript variant X12
microtubule-actin cross-linking factor 1, transcript variant X34
microtubule-actin cross-linking factor 1, transcript variant X37
microtubule-actin cross-linking factor 1, transcript variant X35
microtubule-actin cross-linking factor 1, transcript variant X15
microtubule-actin cross-linking factor 1, transcript variant X11
microtubule-actin cross-linking factor 1, transcript variant X3
microtubule-actin cross-linking factor 1, transcript variant X4
microtubule-actin cross-linking factor 1, transcript variant X10
microtubule-actin cross-linking factor 1, transcript variant X9
microtubule-actin cross-linking factor 1, transcript variant X2
microtubule-actin cross-linking factor 1, transcript variant X22
microtubule-actin cross-linking factor 1, transcript variant X5
microtubule-actin cross-linking factor 1, transcript variant X24
microtubule-actin cross-linking factor 1, transcript variant X14
microtubule-actin cross-linking factor 1, transcript variant X31
microtubule-actin cross-linking factor 1, transcript variant X7
microtubule-actin cross-linking factor 1, transcript variant X13
microtubule-actin cross-linking factor 1, transcript variant X30
microtubule-actin cross-linking factor 1, transcript variant X21
microtubule-actin cross-linking factor 1, transcript variant X8
microtubule-actin cross-linking factor 1, transcript variant X26
microtubule-actin cross-linking factor 1, transcript variant X20
microtubule-actin cross-linking factor 1, transcript variant X6
microtubule-actin cross-linking factor 1, transcript variant X1
microtubule-actin cross-linking factor 1, transcript variant X36
microtubule-actin cross-linking factor 1, transcript variant X29
microtubule-actin cross-linking factor 1, transcript variant X33
microtubule-actin cross-linking factor 1 isoform X38
microtubule-actin cross-linking factor 1 isoform X36
microtubule-actin cross-linking factor 1 isoform X27
microtubule-actin cross-linking factor 1 isoform X26
microtubule-actin cross-linking factor 1 isoform X37
microtubule-actin cross-linking factor 1 isoform X22
microtubule-actin cross-linking factor 1 isoform X18
microtubule-actin cross-linking factor 1 isoform X16
microtubule-actin cross-linking factor 1 isoform X24
microtubule-actin cross-linking factor 1 isoform X17
microtubule-actin cross-linking factor 1 isoform X12
microtubule-actin cross-linking factor 1 isoform X33
microtubule-actin cross-linking factor 1 isoform X15
microtubule-actin cross-linking factor 1 isoform X11
microtubule-actin cross-linking factor 1 isoform X3
microtubule-actin cross-linking factor 1 isoform X4
microtubule-actin cross-linking factor 1 isoform X10
microtubule-actin cross-linking factor 1 isoform X9
microtubule-actin cross-linking factor 1 isoform X2
microtubule-actin cross-linking factor 1 isoform X21
microtubule-actin cross-linking factor 1 isoform X5
microtubule-actin cross-linking factor 1 isoform X23
microtubule-actin cross-linking factor 1 isoform X14
microtubule-actin cross-linking factor 1 isoform X30
microtubule-actin cross-linking factor 1 isoform X7
microtubule-actin cross-linking factor 1 isoform X13
microtubule-actin cross-linking factor 1 isoform X29
microtubule-actin cross-linking factor 1 isoform X20
microtubule-actin cross-linking factor 1 isoform X8
microtubule-actin cross-linking factor 1 isoform X25
microtubule-actin cross-linking factor 1 isoform X19
microtubule-actin cross-linking factor 1 isoform X6
microtubule-actin cross-linking factor 1 isoform X1
microtubule-actin cross-linking factor 1 isoform X34
microtubule-actin cross-linking factor 1 isoform X28
microtubule-actin cross-linking factor 1 isoform X31
microtubule-actin cross-linking factor 1, transcript variant X32
uncharacterized LOC124428430, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124428430, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X2
sodium-dependent neutral amino acid transporter B(0)AT3, transcript variant X1
sodium-dependent neutral amino acid transporter B(0)AT3 isoform X1
sodium-dependent neutral amino acid transporter B(0)AT3 isoform X2
dihydroceramide fatty acyl 2-hydroxylase FAH2, transcript variant X1
dihydroceramide fatty acyl 2-hydroxylase FAH2, transcript variant X2
dihydroceramide fatty acyl 2-hydroxylase FAH2 isoform X1
ceramide very long chain fatty acid hydroxylase scs7 isoform X2
NF-kappa-B inhibitor-interacting Ras-like protein, transcript variant X2
NF-kappa-B inhibitor-interacting Ras-like protein, transcript variant X1
NF-kappa-B inhibitor-interacting Ras-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124428325, transcript variant X2
uncharacterized LOC124428325, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
splicing factor U2af 38 kDa subunit-like
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
medium-chain acyl-CoA ligase ACSF2, mitochondrial isoform X2
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X1
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X2
medium-chain acyl-CoA ligase ACSF2, mitochondrial, transcript variant X3
medium-chain acyl-CoA ligase ACSF2, mitochondrial isoform X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, transcript variant X5
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, transcript variant X3
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform X5
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform X3
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A isoform X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B isoform X4
transient-receptor-potential-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
zinc finger MYND domain-containing protein 11, transcript variant X2
zinc finger MYND domain-containing protein 11, transcript variant X3
zinc finger MYND domain-containing protein 11, transcript variant X4
zinc finger MYND domain-containing protein 11, transcript variant X1
zinc finger MYND domain-containing protein 11 isoform X2
zinc finger MYND domain-containing protein 11 isoform X1
60S ribosome subunit biogenesis protein NIP7 homolog, transcript variant X3
60S ribosome subunit biogenesis protein NIP7 homolog, transcript variant X2
60S ribosome subunit biogenesis protein NIP7 homolog, transcript variant X1
60S ribosome subunit biogenesis protein NIP7 homolog
tyrosine-protein phosphatase corkscrew-like
DNA polymerase delta catalytic subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DNA polymerase delta catalytic subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
DNA polymerase delta catalytic subunit isoform X1
DNA polymerase delta catalytic subunit isoform X2
DNA polymerase delta catalytic subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DNA polymerase delta catalytic subunit isoform X3
DNA polymerase delta catalytic subunit, transcript variant X4
DNA polymerase delta catalytic subunit isoform X4
ADP-ribosylation factor-like protein 1, transcript variant X2
ADP-ribosylation factor-like protein 1, transcript variant X1
ADP-ribosylation factor-like protein 1 isoform X1
ADP-ribosylation factor-like protein 1 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X2
t-SNARE domain-containing protein 1, transcript variant X2
t-SNARE domain-containing protein 1, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2, transcript variant X2
eukaryotic translation initiation factor 4 gamma 2, transcript variant X5
eukaryotic translation initiation factor 4 gamma 2, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2, transcript variant X4
eukaryotic translation initiation factor 4 gamma 2, transcript variant X3
eukaryotic translation initiation factor 4 gamma 2, transcript variant X6
eukaryotic translation initiation factor 4 gamma 2 isoform X1
eukaryotic translation initiation factor 4 gamma 2 isoform X2
transcription initiation factor IIB, transcript variant X1
transcription initiation factor IIB, transcript variant X2
protein shisa-5-like, transcript variant X2
protein shisa-5-like, transcript variant X1
uncharacterized protein LOC124428514 isoform X1
uncharacterized protein LOC124428514 isoform X3
uncharacterized protein LOC124428514 isoform X2
dihydrolipoyl dehydrogenase, mitochondrial
dedicator of cytokinesis protein 3, transcript variant X1
dedicator of cytokinesis protein 3, transcript variant X2
dedicator of cytokinesis protein 3 isoform X1
dedicator of cytokinesis protein 3 isoform X2
protocadherin-like wing polarity protein stan, transcript variant X1
protocadherin-like wing polarity protein stan, transcript variant X2
protocadherin-like wing polarity protein stan, transcript variant X3
protocadherin-like wing polarity protein stan, transcript variant X5
protocadherin-like wing polarity protein stan, transcript variant X4
protocadherin-like wing polarity protein stan isoform X1
protocadherin-like wing polarity protein stan isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 69-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 70% coverage of the annotated genomic feature by RNAseq alignments
plexin domain-containing protein 2-like, transcript variant X1
plexin domain-containing protein 2-like, transcript variant X2
plexin domain-containing protein 2-like, transcript variant X3
plexin domain-containing protein 2-like, transcript variant X4
plexin domain-containing protein 2-like isoform X1
plexin domain-containing protein 2-like isoform X2
plexin domain-containing protein 2-like isoform X3
plexin domain-containing protein 2-like isoform X4
uncharacterized LOC124428303, transcript variant X3
uncharacterized LOC124428303, transcript variant X4
uncharacterized LOC124428303, transcript variant X2
uncharacterized LOC124428303, transcript variant X6
uncharacterized LOC124428303, transcript variant X7
uncharacterized LOC124428303, transcript variant X5
uncharacterized LOC124428303, transcript variant X1
39S ribosomal protein L47, mitochondrial
pleckstrin homology domain-containing family M member 2, transcript variant X1
pleckstrin homology domain-containing family M member 2, transcript variant X2
pleckstrin homology domain-containing family M member 2 isoform X1
uncharacterized protein LOC124428296 isoform X2
cardioacceleratory peptide receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cardioacceleratory peptide receptor-like isoform X1
cardioacceleratory peptide receptor-like isoform X3
cardioacceleratory peptide receptor-like isoform X2
uncharacterized LOC124428301, transcript variant X2
uncharacterized LOC124428301, transcript variant X1
guanine nucleotide-binding protein-like 3 homolog
probable serine/threonine-protein kinase DDB_G0282963
uncharacterized LOC124428448, transcript variant X1
uncharacterized LOC124428448, transcript variant X2
uncharacterized protein LOC124428448 isoform X1
uncharacterized protein LOC124428448 isoform X2
39S ribosomal protein L55, mitochondrial
cystinosin homolog, transcript variant X4
cystinosin homolog, transcript variant X3
cystinosin homolog, transcript variant X5
cystinosin homolog, transcript variant X2
cystinosin homolog, transcript variant X1
rh5-interacting protein-like, transcript variant X2
uncharacterized LOC124428467, transcript variant X2
uncharacterized LOC124428467, transcript variant X1
rh5-interacting protein-like, transcript variant X1
rh5-interacting protein-like, transcript variant X4
rh5-interacting protein-like, transcript variant X5
rh5-interacting protein-like, transcript variant X3
uncharacterized protein LOC124428460 isoform X1
uncharacterized protein LOC124428460 isoform X3
39S ribosomal protein L51, mitochondrial
RNA-binding protein Musashi homolog 2, transcript variant X4
RNA-binding protein Musashi homolog 2, transcript variant X2
RNA-binding protein Musashi homolog 2, transcript variant X5
RNA-binding protein Musashi homolog 2, transcript variant X13
RNA-binding protein Musashi homolog 2, transcript variant X1
RNA-binding protein Musashi homolog 2, transcript variant X3
RNA-binding protein Musashi homolog 2, transcript variant X10
RNA-binding protein Musashi homolog 2, transcript variant X11
RNA-binding protein Musashi homolog 2, transcript variant X12
RNA-binding protein Musashi homolog 2, transcript variant X6
RNA-binding protein Musashi homolog 2, transcript variant X7
RNA-binding protein Musashi homolog 2, transcript variant X8
RNA-binding protein Musashi homolog 2, transcript variant X9
RNA-binding protein Musashi homolog 2, transcript variant X14
RNA-binding protein Musashi homolog 2 isoform X1
RNA-binding protein Musashi homolog 2 isoform X2
RNA-binding protein Musashi homolog 2 isoform X3
protein phosphatase 1 regulatory subunit 21, transcript variant X2
protein phosphatase 1 regulatory subunit 21, transcript variant X1
protein phosphatase 1 regulatory subunit 21 isoform X1
protein phosphatase 1 regulatory subunit 21 isoform X2
iron-sulfur cluster assembly 2 homolog, mitochondrial
transmembrane emp24 domain-containing protein bai
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
small subunit processome component 20 homolog, transcript variant X1
small subunit processome component 20 homolog isoform X1
small subunit processome component 20 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
small subunit processome component 20 homolog, transcript variant X2
small subunit processome component 20 homolog isoform X3
small subunit processome component 20 homolog isoform X2
odorant receptor 4-like, transcript variant X2
odorant receptor 4-like, transcript variant X1
uncharacterized protein LOC124428491 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: odorant receptor 9a-like
neutral and basic amino acid transport protein rBAT-like isoform X1
DNA-directed RNA polymerase I subunit RPA1, transcript variant X2
DNA-directed RNA polymerase I subunit RPA1, transcript variant X1
DNA-directed RNA polymerase I subunit RPA1 isoform X2
DNA-directed RNA polymerase I subunit RPA1 isoform X1
coiled-coil and C2 domain-containing protein 1-like, transcript variant X1
coiled-coil and C2 domain-containing protein 1-like, transcript variant X3
coiled-coil and C2 domain-containing protein 1-like, transcript variant X2
coiled-coil and C2 domain-containing protein 1-like, transcript variant X6
coiled-coil and C2 domain-containing protein 1-like, transcript variant X4
coiled-coil and C2 domain-containing protein 1-like isoform X1
coiled-coil and C2 domain-containing protein 1-like isoform X3
coiled-coil and C2 domain-containing protein 1-like isoform X2
coiled-coil and C2 domain-containing protein 1-like isoform X6
coiled-coil and C2 domain-containing protein 1-like isoform X4
coiled-coil and C2 domain-containing protein 1-like, transcript variant X5
coiled-coil and C2 domain-containing protein 1-like isoform X5
ras-interacting protein RIP3-like, transcript variant X7
ras-interacting protein RIP3-like, transcript variant X1
ras-interacting protein RIP3-like, transcript variant X2
ras-interacting protein RIP3-like, transcript variant X4
circadian locomoter output cycles protein kaput-like isoform X1
circadian locomoter output cycles protein kaput-like isoform X2
ras-interacting protein RIP3-like isoform X4
ras-interacting protein RIP3-like, transcript variant X3
ras-interacting protein RIP3-like, transcript variant X5
ras-interacting protein RIP3-like, transcript variant X6
circadian locomoter output cycles protein kaput-like isoform X3
ras-interacting protein RIP3-like isoform X5
ras-interacting protein RIP3-like isoform X6
ras-interacting protein RIP3-like, transcript variant X8
circadian locomoter output cycles protein kaput-like isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eyes absent homolog 4, transcript variant X5
eyes absent homolog 4, transcript variant X4
eyes absent homolog 4, transcript variant X2
eyes absent homolog 4, transcript variant X11
eyes absent homolog 4, transcript variant X10
eyes absent homolog 4, transcript variant X9
eyes absent homolog 4, transcript variant X8
eyes absent homolog 4, transcript variant X7
eyes absent homolog 4, transcript variant X6
eyes absent homolog 4, transcript variant X1
eyes absent homolog 4, transcript variant X3
nuclear transcription factor Y subunit gamma-like, transcript variant X2
nuclear transcription factor Y subunit gamma-like, transcript variant X1
nuclear transcription factor Y subunit gamma-like isoform X2
nuclear transcription factor Y subunit gamma-like isoform X1
intraflagellar transport protein 52 homolog
pancreatic lipase-related protein 2, transcript variant X1
pancreatic lipase-related protein 2, transcript variant X2
pancreatic lipase-related protein 2 isoform X2